These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35411052)

  • 41. Identification of gut metabolites associated with Parkinson's disease using bioinformatic analyses.
    Yan J; Feng X; Zhou X; Zhao M; Xiao H; Li R; Shen H
    Front Aging Neurosci; 2022; 14():927625. PubMed ID: 35959296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.
    Lubomski M; Xu X; Holmes AJ; Yang JYH; Sue CM; Davis RL
    J Neurol; 2022 Feb; 269(2):780-795. PubMed ID: 34128115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
    Voigt RM; Wang Z; Brown JM; Engen PA; Naqib A; Goetz CG; Hall DA; Metman LV; Shaikh M; Forsyth CB; Keshavarzian A
    Neurobiol Dis; 2022 Aug; 170():105780. PubMed ID: 35654277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-Omics Analysis Reveals a Correlation between the Host Phylogeny, Gut Microbiota and Metabolite Profiles in Cyprinid Fishes.
    Li T; Long M; Li H; Gatesoupe FJ; Zhang X; Zhang Q; Feng D; Li A
    Front Microbiol; 2017; 8():454. PubMed ID: 28367147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson's disease: An animal study.
    Yan Z; Yang F; Sun L; Yu J; Sun L; Si Y; Yao L
    Brain Behav Immun; 2022 Nov; 106():307-321. PubMed ID: 36126853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations of Gut Microbiome and Metabolite Profiles Associated With Anabatic Lipid Dysmetabolism in Thyroid Cancer.
    Lu G; Yu X; Jiang W; Luo Q; Tong J; Fan S; Chai L; Gao D; Qiao T; Wang R; Deng C; Lv Z; Li D
    Front Endocrinol (Lausanne); 2022; 13():893164. PubMed ID: 35721748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leveraging sequence-based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson's disease.
    Ji T; Huang H; Liu J; Peng T; Zhou X; Tan Q; Yuan J; Hua H; Ding S; Liu H
    Eur J Neurosci; 2021 Jan; 53(2):687-696. PubMed ID: 32865266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Metabolites and Gut Microbes between Patients with Parkinson's Disease and Healthy Individuals-A Pilot Clinical Observational Study (STROBE Compliant).
    Kim CH; Jung J; Lee YU; Kim KH; Kang S; Kang GH; Chu H; Kim SY; Lee S
    Healthcare (Basel); 2022 Feb; 10(2):. PubMed ID: 35206916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
    Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
    Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral and gut dysbiosis leads to functional alterations in Parkinson's disease.
    Jo S; Kang W; Hwang YS; Lee SH; Park KW; Kim MS; Lee H; Yoon HJ; Park YK; Chalita M; Lee JH; Sung H; Lee JY; Bae JW; Chung SJ
    NPJ Parkinsons Dis; 2022 Jul; 8(1):87. PubMed ID: 35798742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
    Chernevskaya E; Beloborodova N; Klimenko N; Pautova A; Shilkin D; Gusarov V; Tyakht A
    Crit Care; 2020 Jun; 24(1):312. PubMed ID: 32513224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered gut microbiota in Parkinson's disease patients with motor complications.
    Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
    Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.